Dublin, April 10, 2019 (GLOBE NEWSWIRE) -- The "Breast Imaging Market by Technology [Ionizing (FFDM, Analog, 3D Mammogram, PEM, CT, CBCT, EIT), Non-Ionizing (Breast Ultrasound,Breast MRI, AWBU, Breast Thermography)], End User (Hospital, Diagnostic Imaging Center) - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
Breast imaging market is slated to exhibit a lucrative growth rate. The global breast imaging market is expected to reach $5,185.3 million by 2024, at a CAGR of 8.8% in the forecast period from 2019 to 2024.
This market is mainly driven by rising prevalence and incidence of breast cancer, growing awareness for early detection of breast diseases, technological advancements in breast imaging equipment, increasing investment and funding in R&D for breast cancer treatment, rising women aging population, and launch of advanced systems and software for diagnosing dense breast tissue. Traditionally, various end users were using analog mammography systems. However, this trend is shifting towards digital mammography systems due to their advantages such as high detection rate coupled with breast cancer incidences. The breast imaging market is segmented based on technology-ionizing (full-field digital mammography (FFDM), analog mammography, 3D breast tomosynthesis (DBT), positron emission tomography/computed tomography (PET/CT), molecular breast-specific gamma imaging (MBI/BSGI), positron emission mammography (PEM), computed tomography (CT), cone beam computed tomography (CBCT), and electric impedance tomography (EIT); and non-ionizing- breast ultrasound, breast MRI, automated whole-breast ultrasound (AWBS), breast thermography, and optical imaging; and end user (hospitals, diagnostic imaging centers, and ambulatory surgical centres). On the basis of technology, ionizing technology commanded the largest share. However, non-ionizing technology will grow at the highest CAGR during the forecast period due to their advantages such as accurate detection of breast tumor location and higher sensitivity for smaller breast lesion in dense breast women. Based on end user, hospitals accounted for the largest share due to higher purchasing power, well-equipped operating & diagnostic rooms, presence of highly skilled healthcare professionals, ease in accessibility, and better health coverage for hospital based healthcare services from various private and group insurance plans. On the other hand, Ambulatory Surgical Centers (ASCs) are expected to grow at a fastest CAGR owing to rising preference for outpatient services, quick arrangement of surgery for critical breast cancer patients by eliminating the waiting time at hospitals, most surgery payments to be covered by ASC payment systems, greater autonomy of ASC physicians, and rising number of surgeries performed across ASCs. An in-depth analysis of the geographical scenario of the industry provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. The geographic analysis provides detailed insights on the key trends of the industry in the listed regions & countries, identifying the demographic & economic impact, and government & private investments. On the basis of geography, Asia Pacific region is expected to register the highest CAGR during the forecast period. The high growth will be mainly due to accelerated economic growth of many countries, growing government focus on healthcare sector, rising incidence & prevalence of breast tumor, increasing health insurance penetration, and a rising female aging population in the region. Key players operating in the global breast imaging market include Hologic, Inc., GE Healthcare, Siemens Healthcare GmbH, Carestream Health Inc., Koninklijke Philips N.V., FUJIFILM Holdings America Corporation, Canon Medical Systems Corporation, Hitachi Medical Systems, Aurora healthcare US Corporation, Dilon Technologies, Inc., CMR Naviscan Corporation, Planmed OY, and SonoCine Inc. among others.
Key Topics Covered
1. Introduction 1.1. Market Ecosystem 1.2. Currency and Limitations 1.3. Key Stakeholders 2. Research Methodology 2.1. Research Process 2.1.1. Secondary Research 2.1.2. Primary Research 2.1.3. Market Size Estimation 3. Executive Summary 4. Market Insight 4.1. Introduction 4.2. Drivers 4.2.1. Rising Prevalence and Incidence of Breast Cancer 4.2.2. Growing Awareness for Early Detection of Breast Diseases 4.2.3. Technological Advancements in Breast Imaging Equipment 4.2.4. Increasing Investment and Funding in R&D for Breast Cancer Treatment 4.2.5. Rising Women Aging Population 4.2.6. Launch of Advanced System and Software for Diagnosing Dense Breast Tissue 4.3. Restraints 4.3.1. High Cost of Breast Imaging Equipment 4.3.2. Errors Associated with Breast Screening and Diagnosing 4.3.3. Stringent Regulatory Approval Procedure 4.4. Opportunities 4.4.1. Extensive Research in the Development of Hybrid Imaging Systems 5. Global Breast Imaging Market, by Technology 5.1. Introduction 5.2. Ionizing Technology 5.2.1. Full-Field Digital Mammography (FFDM) 5.2.2. Analog Mammography 5.2.3. 3d Breast Tomosynthesis 5.2.4. Positron Emission Tomography/Computed Tomography (PET/CT) 5.2.5. Molecular Breast-Specific Gamma Imaging (MBI/BSGI) 5.2.6. Positron Emission Mammography (PEM) 5.2.7. Computed Tomography (CT) 5.2.8. Cone Beam Computed Tomography (CBCT) 5.2.9. Electric Impedance Tomography (EIT) 5.3. Non-Ionizing Technology 5.3.1. Breast Ultrasound 5.3.2. Breast MRI 5.3.3. Automated Whole-Breast Ultrasound (AWBU) 5.3.4. Breast Thermography 5.3.5. Optical Imaging 6. Global Breast Imaging Market, by End User 6.1. Introduction 6.2. Hospitals 6.3. Diagnostic Imaging Centers 6.4. Academic and Research Institutes 6.5. Ambulatory Surgical Centers (ASCs) 7. Breast Imaging Market, by Geography 7.1. Introduction 7.2. North America 7.3. Europe 7.4. Asia-Pacific 7.5. Rest of the World 8. Competitive Landscape 8.1. Competitive Benchmarking 9. Company Profiles (Includes Business Overview, Financial Overview, Product Portfolio, and Strategic Developments) 9.1. Hologic Inc. 9.2. GE Healthcare 9.3. Siemens Healthcare GmbH (Subsidiary of Siemens AG) 9.4. Carestream Health Inc. 9.5. Koninklijke Philips N.V. 9.6. Fujifilm Holdings America Corporation (Subsidiary of Fujifilm Holding Corporation) 9.7. Canon Medical Systems Corporation (Subsidiary of Canon Inc.) 9.8. Hitachi Healthcare Americas Ltd. (Subsidiary of Hitachi Medical Corporation) 9.9. Aurora Healthcare US Corporation 9.10. Dilon Technologies Inc. 9.11. CMR Naviscan Corporation 9.12. Planmed OY 9.13. SonoCine Inc.
For more information about this report visit https://www.researchandmarkets.com/r/y6hmpv
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Medical Imaging, Computed Tomography, Mammography, Magnetic Resonance Imaging (MRI), Ultrasound
